 |
|
Epidemiology of Kawasaki disease in infants 3 months of age and younger
Eun Jung Lee (Lee EJ), Yong Won Park (Park YW), Young Mi Hong (Hong YM), Joon Sung Lee (Lee JS), Ji Whan Han (Han JW)
Clin Exp Pediatr. 2012;55(6):202-205. Published online 2012 Jun 21 DOI: https://doi.org/10.3345/kjp.2012.55.6.202
|
|
Citations to this article as recorded by
 Acalculous Cholecystitis From Kawasaki Disease in a Three-Month-Old Girl: A Rare Sign at an Uncommon Age
Hansa Sriphongphankul, Jirayut Jarutach, Thampapon Chaisujyakorn, Supika Kritsaneepaiboon, Phurich Janjindamai
Cureus.2024;[Epub] CrossRef Kawasaki disease in Malaysia: Biochemical profile, characterization, diagnosis and treatment
Chooi San Cheah, Wendy Wei Li Lee, Siti Aisyah Suhaini, Abdullah Harith Azidin, Mohammad Shukri Khoo, Noor Akmal Shareela Ismail, Adli Ali
Frontiers in Pediatrics.2023;[Epub] CrossRef Bacille Calmette-Guérin Site Reactivation of Kawasaki Disease in Infants under 3 Months of Age: Relation with Diagnosis and Prognosis
Da Eun Roh, Jung Eun Kwon, Yeo Hyang Kim
Children.2022; 9(6): 857. CrossRef Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range
Qu-ming Zhao, Min Huang, Mei-rong Huang, Sun Chen, Fang Liu, Guo-ying Huang
Clinical Rheumatology.2021; 40(4): 1515. CrossRef Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial
Si-Yuan Lin, Lan He, Li-Ping Xie, Yin Wang, Yi-Xiang Lin, Yin-Yin Cao, Wei-Li Yan, Fang Liu, Guo-Ying Huang
Trials.2021;[Epub] CrossRef Association between the miRNA‐149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population
Jiawen Li, Jinxin Wang, Xiaoping Su, Zhiyong Jiang, Xing Rong, Xueping Gu, Chang Jia, Lanlan Zeng, Hao Zheng, Xiaoqiong Gu, Maoping Chu
Journal of Clinical Laboratory Analysis.2020;[Epub] CrossRef Neonatal Kawasaki disease with multiple arterial aneurysms: a case report
Qu-ming Zhao, Xue-cun Liang, Lin Wu, Fang Liu
Pediatric Rheumatology.2020;[Epub] CrossRef Kawasaki Disease in Infants in the First 3 Months of Age in a Mexican Population: A Cautionary Tale
Luis Martín Garrido-García, Juan Humberto Gutiérrez-Alanis, Ana Isabel Ramírez-Perea, Adriana Tremoulet, Marco Antonio Yamazaki-Nakashimada
Frontiers in Pediatrics.2020;[Epub] CrossRef Clinical features and mid‐term follow‐up in infants younger than 3 months with Kawasaki disease in a Chinese population
Wei Li, Li Zhang, Ping Huang, Zhiwei Zhang
Journal of Paediatrics and Child Health.2019; 55(5): 523. CrossRef Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study
Carlos Daniel Grasa, Elisa Fernandez-Cooke, Judith Sánchez-Manubens, Jordi Antón, David Crespo, Moneyba García, Agustín López, María José Lirola Cruz, Rafael Díaz-Delgado de la Peña, Cristina Calvo
Annals of the Rheumatic Diseases.2019; 78(2): 289. CrossRef Kawasaki disease in infants less than one year of age: an Italian cohort from a single center
Greta Mastrangelo, Rolando Cimaz, Giovani Battista Calabri, Gabriele Simonini, Donatella Lasagni, Massimo Resti, Sandra Trapani
BMC Pediatrics.2019;[Epub] CrossRef Treatment Options for Resistant Kawasaki Disease
Linny Kimly Phuong, Nigel Curtis, Peter Gowdie, Jonathan Akikusa, David Burgner
Pediatric Drugs.2018; 20(1): 59. CrossRef Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method
Kaoru Satoh, Yoko Wakejima, Maki Gau, Tomoyuki Kiguchi, Nozomi Matsuda, Reiko Takasawa, Kei Takasawa, Masato Nishioka, Masayuki Shimohira
International Journal of Rheumatic Diseases.2018; 21(3): 746. CrossRef A 3-month-old infant with atypical Kawasaki disease
Nichkamol Lertamornkitti, Anchalee Wangjirapan
BMJ Case Reports.2018; : bcr-2017-221456. CrossRef Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study
You Min Yoon, Hye Won Yun, Sung Hye Kim
Korean Circulation Journal.2016; 46(4): 550. CrossRef Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)
Reiko Aoyagi, Hiromichi Hamada, Yasunori Sato, Hiroyuki Suzuki, Yoshihiro Onouchi, Ryota Ebata, Kengo Nagashima, Moe Terauchi, Masaru Terai, Hideki Hanaoka, Akira Hata
BMJ Open.2015; 5(12): e009562. CrossRef Epidemiologic Features and Prognostic Factors of Coronary Artery Lesions Associated With Kawasaki Disease Based on a 13-Year Cohort of Consecutive Cases Identified by Complete Enumeration Surveys in Wakayama, Japan
Naomi Kitano, Hiroyuki Suzuki, Takashi Takeuchi, Tomohiro Suenaga, Nobuyuki Kakimoto, Shoichi Shibuta, Norishige Yoshikawa, Tatsuya Takeshita
Journal of Epidemiology.2014; 24(5): 427. CrossRef Neonatal Kawasaki disease: case report and data from nationwide survey in Japan
Mayumi Hangai, Yasuo Kubota, Jiro Kagawa, Mayumi Yashiro, Ritei Uehara, Yosikazu Nakamura, Masato Takeuchi
European Journal of Pediatrics.2014; 173(11): 1533. CrossRef Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age
Hyun Kyung Bae, Do Kyung Lee, Jung Hyun Kwon, Hae Soon Kim, Sejung Sohn, Young Mi Hong
Korean Journal of Pediatrics.2014; 57(8): 357. CrossRef Kawasaki disease in infants
Jung Sook Yeom, Hyang Ok Woo, Ji Sook Park, Eun Sil Park, Ji-Hyun Seo, Hee-Shang Youn
Korean Journal of Pediatrics.2013; 56(9): 377. CrossRef Concurrent Adrenal Neuroblastoma and Kawasaki Disease: A Report of a Rare Case
Samin Alavi, Alireza Fahimzad, Farzaneh Jadali, Farid Ghazizadeh, Armin Rashidi
Case Reports in Pediatrics.2013; 2013: 1. CrossRef
|